PT3869199T - Método e reagentes para o diagnóstico de sars-cov-2 - Google Patents

Método e reagentes para o diagnóstico de sars-cov-2

Info

Publication number
PT3869199T
PT3869199T PT202154456T PT20215445T PT3869199T PT 3869199 T PT3869199 T PT 3869199T PT 202154456 T PT202154456 T PT 202154456T PT 20215445 T PT20215445 T PT 20215445T PT 3869199 T PT3869199 T PT 3869199T
Authority
PT
Portugal
Prior art keywords
cov
sars
reagents
diagnosis
Prior art date
Application number
PT202154456T
Other languages
English (en)
Original Assignee
Euroimmun Medizinische Labordiagnostika Ag
Univ Berlin Charite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=69726444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3869199(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euroimmun Medizinische Labordiagnostika Ag, Univ Berlin Charite filed Critical Euroimmun Medizinische Labordiagnostika Ag
Publication of PT3869199T publication Critical patent/PT3869199T/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
PT202154456T 2020-02-20 2020-02-20 Método e reagentes para o diagnóstico de sars-cov-2 PT3869199T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20158626.0A EP3715847A1 (en) 2020-02-20 2020-02-20 A method and reagents for the diagnosis of sars-cov-2
EP20215445.6A EP3869199B1 (en) 2020-02-20 2020-02-20 A method and reagents for the diagnosis of sars-cov-2

Publications (1)

Publication Number Publication Date
PT3869199T true PT3869199T (pt) 2022-03-02

Family

ID=69726444

Family Applications (1)

Application Number Title Priority Date Filing Date
PT202154456T PT3869199T (pt) 2020-02-20 2020-02-20 Método e reagentes para o diagnóstico de sars-cov-2

Country Status (10)

Country Link
EP (3) EP3869199B1 (pt)
DE (1) DE20158626T1 (pt)
DK (1) DK3869199T3 (pt)
ES (2) ES2788459T1 (pt)
HR (1) HRP20220373T1 (pt)
HU (1) HUE058338T2 (pt)
LT (1) LT3869199T (pt)
PL (1) PL3869199T3 (pt)
PT (1) PT3869199T (pt)
SI (1) SI3869199T1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021186029A1 (en) * 2020-03-20 2021-09-23 Deutsches Krebsforschungszentrum Sars spike peptides and uses thereof
GB202006815D0 (en) * 2020-05-07 2020-06-24 Senseutics Ltd Method
WO2021222988A1 (en) * 2020-05-07 2021-11-11 Griffith University Cell entry-modulating agents and uses therefor
EP3734286A1 (en) 2020-05-15 2020-11-04 Euroimmun Medizinische Labordiagnostika AG A method for determining the efficacy of a sars-cov-2 vaccine
CN111551715B (zh) * 2020-05-18 2022-04-22 天津博奥赛斯生物科技股份有限公司 一种新型冠状病毒IgM抗体的酶联免疫法检测试剂盒
EP3913369A1 (en) * 2020-05-20 2021-11-24 Diesse Diagnostica Senese S.p.a. Method for inactivating sars-cov-2 and uses thereof
CN111848753B (zh) * 2020-07-20 2022-03-15 中国科学院过程工程研究所 新型冠状病毒抗原表位及其应用
DE102020125915B3 (de) 2020-10-02 2022-03-03 Institut für Molekulare Diagnostik und Bioanalytik Immundiagnostische mittel und verfahren für den nachweis und die differenzierung von coronavirus-infektionen
CN112251414A (zh) * 2020-10-12 2021-01-22 中国科学院苏州纳米技术与纳米仿生研究所 一种杂交瘤细胞株、其制备方法和应用
KR20220054080A (ko) * 2020-10-23 2022-05-02 주식회사 와이바이오로직스 SARS-CoV-2 스파이크 단백질에 특이적으로 결합하는 항체 및 이의 용도
WO2022104002A2 (en) * 2020-11-12 2022-05-19 Tscan Therapeutics, Inc. Sars-cov-2 immunodominant peptide constructs and uses thereof
WO2022109751A1 (en) * 2020-11-27 2022-06-02 The University Of Western Ontario Point-of-care testing for sars-cov antibodies
EP4263576A2 (en) * 2020-12-18 2023-10-25 The Scripps Research Institute Immunogenic compositions
CN112611870B (zh) * 2020-12-21 2022-09-16 杭州宝临生物科技有限公司 预测新型冠状病毒中和抗体效价的方法及其试剂盒
CN112379090B (zh) * 2021-01-07 2021-04-16 北京百普赛斯生物科技股份有限公司 新型冠状病毒抗体检测试剂盒及其制备方法与应用
CN112946261A (zh) * 2021-01-14 2021-06-11 广州中医药大学顺德医院(佛山市顺德区中医院) 一种基于三聚体s蛋白rbd-ace2结合竞争的新冠病毒中和抗体检测试剂盒
CN112415189B (zh) * 2021-01-22 2021-03-30 北京百普赛斯生物科技股份有限公司 偶联新型冠状病毒s2蛋白的磁珠及其制备方法与应用
WO2022159834A1 (en) * 2021-01-22 2022-07-28 La Jolla Institute For Immunology Chimeric anti-coronavirus spike protein antibodies
CN113278067B (zh) * 2021-02-09 2022-06-28 武汉中生毓晋生物医药有限责任公司 一种新型冠状病毒猪源性免疫球蛋白的制备方法
CN113238046A (zh) * 2021-04-30 2021-08-10 深圳迈瑞生物医疗电子股份有限公司 检测冠状病毒抗体的试剂盒、冠状病毒抗体的检测方法
CN114371159B (zh) * 2021-05-19 2023-11-07 南京医科大学第二附属医院 一种rna生物芯片及其制备方法与应用
CN114231497B (zh) * 2022-02-24 2022-05-20 广州伯尼兹生物科技有限公司 一株表达SARS-CoV-2 S1蛋白单克隆抗体杂交瘤细胞系及中和活性抗体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1648927A1 (en) 2003-07-21 2006-04-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Soluble fragments of the sars-cov spike glycoprotein
US20050112559A1 (en) * 2003-09-29 2005-05-26 The Chinese University Of Hong Kong Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS)
US20050282154A1 (en) 2003-10-06 2005-12-22 The Brigham And Women's Hospital, Inc. Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus
US7491397B2 (en) 2004-01-09 2009-02-17 National Health Research Institutes Receptor binding polypeptides
EP1751178A2 (en) * 2004-06-04 2007-02-14 Institut Pasteur Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
US20060188519A1 (en) * 2004-06-14 2006-08-24 To Cheung Peptides, antibodies, and methods for the diagnosis of SARS
US20080269115A1 (en) * 2004-06-17 2008-10-30 Beadenkopf Robert J Immunogenic Sars Domain
ES2790841T3 (es) 2012-09-23 2020-10-29 Univ Erasmus Med Ct Rotterdam Betacoronavirus humano del Linaje C e identificación de la dipeptidil peptidasa N-terminal como su receptor viral

Also Published As

Publication number Publication date
SI3869199T1 (sl) 2022-05-31
DE20158626T1 (de) 2020-12-10
EP3869199B1 (en) 2022-02-09
EP3869199A1 (en) 2021-08-25
EP3715847A1 (en) 2020-09-30
LT3869199T (lt) 2022-07-11
DK3869199T3 (da) 2022-03-07
ES2910184T3 (es) 2022-05-11
EP3869200A1 (en) 2021-08-25
HUE058338T2 (hu) 2022-07-28
PL3869199T3 (pl) 2022-05-30
ES2788459T1 (es) 2020-10-21
HRP20220373T1 (hr) 2022-05-13

Similar Documents

Publication Publication Date Title
SI3869199T1 (sl) Postopek in reagenti za diagnozo SARS-COV-2
EP3762805A4 (en) SYSTEM AND PROCEDURE FOR VERIFICATION OF AUTOMATED CLINICAL DOCUMENTATION
EP3761861A4 (en) AUTOMATED CLINICAL DOCUMENTATION SYSTEM AND PROCESS
GB201802123D0 (en) A method of processomg a biological sample
PL3671244T3 (pl) Urządzenie i sposób analizy stanu akumulatora
IL296011A (en) A method for measuring the brow value of a sample
PL3688543T3 (pl) Sposób nawigacji robota oraz robot do wykonywania sposobu
GB202207821D0 (en) Methods and systems for automated clinical workflows
GB202105867D0 (en) Method of developing and using a tool and the resulting tool, for automating complex processes
GB202008994D0 (en) Assay method
EP3988940A4 (en) FULLY AUTOMATIC MACHINE FOR BIOLOGICAL EVALUATION AND CHEMICAL ANALYSIS AND PROCESSES
EP3847457A4 (en) BODY FLUID TESTING PROCEDURE
GB201914089D0 (en) Apparatus and method for determining a biological characteristic
EP4146765C0 (en) METHODS AND REAGENTS FOR INCREASING THE CHEMILUMINESCENT SIGNAL
EP4147228A4 (en) SYSTEM AND METHOD FOR AUTOMATED CLINICAL DOCUMENTATION USING MULTIPLE MICROPHONES
EP4061218A4 (en) METHOD AND SYSTEM FOR EVALUATING BIOLOGICAL MOVEMENT
IL281333A (en) A method to reduce the risk in a clinical trial
GB202000634D0 (en) Diagnostic method
KR102300234B9 (ko) 진단보조정보를 제공하는 방법 및 이를 수행하는 장치
SG10201900431QA (en) A sterile reagent preparation device and the method of using the same
EP3879258A4 (en) EQUIPMENT AND METHODS FOR ANALYZING A FLUID
EP3623999C0 (en) SYSTEM AND DEVICE FOR DETECTING AND ANALYZING A PERSON'S GAIT
GB2609987B (en) Diagnostic method
GB202102823D0 (en) Diagnostic method
GB202100158D0 (en) Diagnostic method